Enzyme Finance

Description sourced from DeFiLlama's protocol metadata; teams submit their own copy when listing.

Enzyme Finance's governance or utility token carries a market capitalisation of 12,3 M $US based on circulating supply at the latest DeFiLlama snapshot. The token's market cap (12,3 M $US) is small relative to deposits secured by the protocol (91,4 M $US); a mcap/TVL multiple of 0.13× is sometimes read as a discount, though it can also reflect minimal fee accrual to the token.

Market cap and supply figures are sourced from DeFiLlama's price feed (which reconciles CoinGecko, CoinMarketCap, and on-chain DEX prices). Treasury and staking values reflect on-chain balances controlled by the protocol at last sync.

Enzyme Finance is a Indexes — a decentralised exchange where users swap assets against on-chain liquidity pools rather than a central order book. It is deployed across 3 chains, including Ethereum, Polygon, Arbitrum. The codebase has been independently audited (1 report on file).

Enzyme Finance operates on 3 networks (Ethereum, Polygon, Arbitrum), keeping its surface area narrower than chain-agnostic peers. Roughly 100% of its on-chain value sits on just three networks (Ethereum, Polygon, Arbitrum), so a fault on any one of them would affect a large slice of users. Price discovery relies on 2 oracle providers (Chainlink, RedStone), which diversifies the data-feed surface but also expands the set of third parties users implicitly trust. Only one audit report is currently listed; users should weigh that against the protocol's TVL before depositing significant amounts. Its token market cap (12,3 M $US) is small relative to TVL (91,4 M $US) — a mcap/TVL ratio of 0.13 is often read as the token being structurally undervalued versus the activity it secures.

Verified external resources for Enzyme Finance — use these to read the source code, follow governance discussions, or cross-check on-chain data against the original team's channels.